Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel

Maria C B de Leon; Sridhar Bolla; Barbra Greene; Lauren Hutchinson; Giuseppe Del Priore

doi:10.1016/j.gynor.2013.05.003

Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel

Gynecol Oncol Case Rep. 2013 May 14:5:70-1. doi: 10.1016/j.gynor.2013.05.003. eCollection 2013.

Authors

Maria C B de Leon¹, Sridhar Bolla², Barbra Greene¹, Lauren Hutchinson¹, Giuseppe Del Priore¹

Affiliations

¹ Indiana University, Gynecologic Oncology Division, 535 Barnhill Drive, Rm 435, Indianapolis, IN 46202, USA.
² American Health Network Hematology Oncology, 1111 Ronald Reagan Pkwy #B1500, Avon, IN 46123, USA.

Abstract

•First case report of successfully treating severe paclitaxel and docetaxel hypersensitivity reaction with nab-paclitaxel•We demonstrated that nab-paclitaxel is a safe taxane chemotherapy treatment option for patients who could not tolerate paclitaxel or docetaxel.

Keywords: Abraxane; Docetaxel; Hypersensitivity reaction; Nab-paclitaxel; Paclitaxel; Taxol.